Arzoxifene Eli Lilly.
Arzoxifene is a benzothiophene second-generation selective estrogen receptor modulator (SERM) under development by Eli Lilly & Co as a potential treatment for cancer.
Animals↗
Biomedical subjects
Micheal W DeGregorio
Publications and source records attributed to Micheal W DeGregorio.